Immune Management ApS: Financial statements 2019
CVR: 38726137
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Immune Management ApS (CVR 38726137) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 621,142 and a net result of DKK 98,704 compared with DKK -55,292 the year before. That is an increase of 24.2% compared with the year before. Equity in the 2019 report amounted to DKK 401,464. The solvency ratio was 79.4%.
- Gross Profit
- DKK 621,142
- Profit/Loss
- DKK 98,704
- Equity
- DKK 401,464
- Total Assets
- DKK 505,550
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 621K | 99K | 401K | - |
| 2018 | - | 500K | -55K | 303K | 1 |
| 2017 | - | 818K | 111K | 358K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Immune Management ApS has published its annual report for 2018. Gross profit came to DKK 500,123, and the net result was DKK -55,292.
About Immune Management ApS
Immune Management ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2017. The company has been dissolved on 2 December 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK -13,493 and a net result of DKK -15,195 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK 41,224.